Related Experiment Videos
Nuclear receptors as potential targets for modulating reverse cholesterol transport
Patricia D Pelton1, Mona Patel, Keith T Demarest
1Department of Drug Discovery, Endocrine Therapeutics and Metabolic Diseases, Johnson & Johnson Pharmaceutical Research and Development, LLC., 1000 Route 202, Raritan, NJ 08869, USA. Ppelton@prdus.jnj.com
Current Topics in Medicinal Chemistry
|April 29, 2005
Summary
Nuclear receptors regulate genes for cholesterol transport and HDL metabolism. Modulating these receptors offers potential therapies for cardiovascular disease and atherosclerosis.
Area of Science:
- Molecular Biology
- Cardiovascular Science
- Pharmacology
Background:
- Cholesterol transport is crucial for preventing cardiovascular diseases like atherosclerosis.
- High-density lipoprotein (HDL) plays a key role in reverse cholesterol transport (RCT).
- Dyslipidemias and cardiovascular disease necessitate novel therapeutic targets.
Purpose of the Study:
- To review the role of nuclear receptors in regulating genes involved in cholesterol transport.
- To explore the therapeutic potential of synthetic modulators targeting these nuclear receptors.
- To understand the physiological roles of nuclear receptors as lipid sensors.
Main Methods:
- Review of literature on nuclear receptors and their role in HDL metabolism.
- Analysis of gene regulation pathways in cholesterol transport.
- Examination of synthetic ligands and their effects on nuclear receptors.
Main Results:
- Nuclear receptors, particularly RXR heterodimers (PPARs, LXR, FXR), regulate key genes in HDL metabolism and RCT.
- Specific ligands for these receptors have elucidated their function as lipid sensors.
- Modulators of these receptors show potential therapeutic utility in dyslipidemias.
Conclusions:
- Nuclear receptors are critical regulators of cholesterol homeostasis and RCT.
- Targeting nuclear receptors with synthetic modulators presents a promising therapeutic strategy for cardiovascular disease.
- Further research into these pathways could lead to effective treatments for atherosclerosis.